Early responses to 3 mm resilient stabilization appliance therapy for sub-acute and chronic temporomandibular disorder pain predict 12-months follow-up outcomes. Issue 1 (2nd January 2022)

• Record Type: Journal Article
• Authors: Emshoff, R diger; Bertram, Annika; Stigler, Robert Gerhard; Schnabl, Dagmar
• Is Part Of: Cranio. Volume 40:Issue 1(2022)
• Page Start: 72
• Page End: 78
• Publication Date: 2022-01-02
• Subjects: Temporomandibular disorders -- chronic pain -- resilient splint; Temporomandibular joint disorders -- periodicals; Temporomandibular joint -- Diseases -- Periodicals; 617.51
• DOI: 10.1080/08869634.2019.1677301
• Languages: English
• ISSNs: 0886-9634

Abstract

ABSTRACT: Objective : To estimate whether outcomes at 12-month follow-up may be predicted by an intermediate and early response to a 3 mm resilient splint therapy for unilateral arthralgia and myofascial pain assessed at 3- and 6-month follow-ups. Methods : Data obtained from one retrospective cohort study consisting of 78 patients suffering from chronic and sub-acute unilateral arthralgia and myofascial pain who were managed with 3 mm resilient splint therapy were subjected to analysis. Results : Baseline visual analog scale (VAS) intensity, gender as well as changes in the intensity of VAS pain at 3- and 6-month follow-ups predicted unilateral arthralgia and myofascial pain group membership ( p < .001). The function classified 83.3% of the cross-validated and 87.2% of original grouped cases correctly. Discussion : The proposed model may be used to timely identify patients who are at risk of developing prolonged non-responsive unilateral arthralgia and myofascial pain chronicity.